John Overdeck’s Annovis Bio ANVS Stock Holding History

John Overdeck’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Sell	579,571 -48,088	-8%	-$93.5K	﹤0.01%	3562
2026 Q1	$1.4M	Buy	627,659 +75,822	+14%	+$208K	﹤0.01%	3016
2025 Q4	$1.91M	Buy	+551,837	New	+$1.66M	﹤0.01%	2470
2025 Q2	–	Sell	-166,219	Closed	-$249K	–	3169
2025 Q1	$249K	Buy	166,219 +155,296	+1,422%	+$475K	﹤0.01%	2788
2024 Q4	$54.9K	Buy	+10,923	New	+$79.1K	﹤0.01%	3035
2022 Q1	–	Sell	-51,747	Closed	-$910K	–	2660
2021 Q4	$910K	Sell	51,747 -45,819	-47%	-$1.18M	﹤0.01%	2644
2021 Q3	$3.1M	Buy	+97,566	New	+$5.61M	0.01%	1586

Other funds holding ANVS

EAM

Empery Asset Management New York $86.5M AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

John Overdeck's ANVS Position: Q2 2026 in Review

John Overdeck reduced its Annovis Bio (ANVS) stake by 7.7% in Q2 2026, selling an estimated $93.5K and leaving 579,571 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #3562.

John Overdeck first reported a position in ANVS in Q3 2021 and has held it in 7 quarters since. The position peaked at $3.1M in Q3 2021. 61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

John Overdeck held 579,571 shares of Annovis Bio worth $1.08M as of Q2 2026.
John Overdeck sold 48,088 Annovis Bio shares in Q2 2026, an estimated $93.5K.
Annovis Bio made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #3562 holding.
John Overdeck first reported a position in Annovis Bio in Q3 2021 and has held it in 7 quarters since.
John Overdeck's Annovis Bio position peaked at $3.1M in Q3 2021.
61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.